Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
INTEGRAL DIAGNOSTICS LIMITED (IDX)ASX AI Signals has generated 6 signals for IDX during the last 90 days, indicating strong trading activity and ongoing AI monitoring
Latest IDX Signals | |
| 23/06/2026 | SELL |
| 10/06/2026 | SELL |
| 15/05/2026 | SELL |
IDX Share Price | |
| Current Price | $2.020 |
| 52 Week High | $2.968 |
| 52 Week Low: | $1.940 |
| Trading at (% of 52 Week High) | 68.06% |
Integral Diagnostics Limited (ASX: IDX) is an Australian company that provides medical imaging services including X-rays, CT scans, MRI, ultrasound, and nuclear medicine. It operates a network of diagnostic imaging centers across Australia and New Zealand, serving hospitals, medical practitioners, and patients.
The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.
The SELL recommendation for INTEGRAL DIAGNOSTICS LIMITED (IDX) is supported by technical indicators suggesting downward momentum and potential overvaluation at the current price of 1.9400. Market conditions and sector-specific challenges also contribute to the bearish outlook.
As the Australian market navigates a period of fluctuating performance, with recent gains tempered by external pressures such as rising oil prices and missed opportunities in the AI sector, investors are on the lookout for stocks that may be trading below their estimated value. In this environment, As global markets navigate a complex landscape marked by resilient U.S. labor data, robust corporate earnings, and geopolitical tensions, small-cap stocks have shown notable dynamism. The recent rally in key indices such as the Russell 2000 highlights investor interest in these companies, often driv In the current global market landscape, small-cap stocks have been gaining attention as the Russell 2000 Index has shown a notable year-to-date increase of 15.28%, reflecting broader investor interest in smaller companies amid strong corporate earnings and resilient economic indicators. With U.S. eq As geopolitical tensions and fluctuating energy prices continue to impact global markets, Asian small-cap stocks are navigating a landscape marked by uncertainty. Despite these challenges, opportunities may arise for investors who focus on companies demonstrating resilience and strategic insider act It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in Integral Diagnostics Limited's (ASX:IDX) case, it's fantastic news for shareholders.
While insider transactions are not the most important thing when it comes to long-term invLatest INTEGRAL DIAGNOSTICS LIMITED(IDX) News
Integral Diagnostics And 2 Other ASX Stocks That May Be Trading Below Estimated Value
Global Undervalued Small Caps With Insider Action For May 2026
Exploring 3 Undervalued Small Caps In Global With Insider Action
Exploring Asian Undervalued Small Caps With Insider Action In March 2026
Positive Signs As Multiple Insiders Buy Integral Diagnostics Stock
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial